Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.34 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6266756 | 0.94 | LPAR3 (0.40) | CYP3A4SMPD1L3MBTL1CA1CA2 | |
| SCHEMBL2379992 | 0.92 | SMPD1 (0.43) | CYP3A4SMPD1CA1CA2LPAR1 | |
| SCHEMBL2521683 | 0.87 | CYP3A4 (0.34) | CYP3A4TSHRSMPD1L3MBTL1CA1 | |
| SCHEMBL6273302 | 0.86 | CYP3A4 (0.45) | CYP3A4TSHRHPGDSMN1; SMN2SMPD1 | |
| SCHEMBL6271516 | 0.86 | CYP3A4 (0.45) | CYP3A4TSHRHPGDSMN1; SMN2SMPD1 | |
| SCHEMBL21291955 | 0.84 | SMPD1 (0.43) | CYP3A4TSHRSMPD1LPAR1LPAR3 | |
| SCHEMBL2049378 | 0.84 | SMPD1 (0.56) | CYP3A4TSHRSMPD1LPAR1LPAR3 | |
| SCHEMBL6269585 | 0.80 | SMPD1 (0.47) | CYP3A4SMPD1L3MBTL1CA1CA2 | |
| SCHEMBL6271799 | 0.80 | SMPD1 (0.43) | CYP3A4TSHRSMPD1L3MBTL1CA1 | |
| SCHEMBL2311733 | 0.79 | ADRB2 (0.41) | CYP3A4TSHRCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2337805-B2 | POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE | MITSUI CHEMICALS INC (JP) | 2025-06-18 | — | — | EP | disclosed |
| EP-3129353-B1 | METHOD FOR MANUFACTURING XYLYLENE DIISOCYANATES IN THE GASEOUS PHASE | COVESTRO DEUTSCHLAND AG (DE) | 2024-02-28 | — | — | EP | disclosed |
| WO-2023106258-A1 | POLYMERIZABLE COMPOSITION FOR MANUFACTURING MOLDED ARTICLE, MOLDED ARTICLE AND MANUFACTURING METHOD THEREOF | MITSUI CHEMICALS, INC. (JP) | 2023-06-15 | — | — | WO | disclosed |
| CN-106414538-B | Composition for producing transparent polythiourethane bodies | 科思创德国股份有限公司 | 2020-02-28 | — | — | CN | disclosed |
| US-10294198-B2 | Method for producing xylylene diisocyanates in the gaseous phase | COVESTRO DEUTSCHLAND AG (DE) | 2019-05-21 | — | — | US | disclosed |
| US-10252988-B2 | Composition for producing transparent polythiourethane bodies | COVESTRO DEUTSCHLAND AG (DE) | 2019-04-09 | — | — | US | disclosed |
| US-20170210702-A1 | METHOD FOR PRODUCING XYLYLENE DIISOCYANATES IN THE GASEOUS PHASE | COVESTRO DEUTSCHLAND AG (DE) | 2017-07-27 | — | — | US | disclosed |
| US-20170121449-A1 | COMPOSITION FOR PRODUCING TRANSPARENT POLYTHIOURETHANE BODIES | MITSUI CHEMICALS, INC. (JP) | 2017-05-04 | — | — | US | disclosed |
| US-20170029552-A1 | COMPOSITION CONTAINING AROMATIC NITRILES FOR THE PRODUCTION OF TRANSPARENT POLYTHIOURETHANE BODIES | COVESTRO DEUTSCHLAND AG (DE) | 2017-02-02 | — | — | US | disclosed |
| EP-2337805-B1 | POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE | ACOMON AG (CH) | 2014-12-17 | — | — | EP | disclosed |
| US-8829147-B2 | Polymerizable liquid composition and process for the production of organic glass starting from polymerizable liquid compositions of the polyurethane type | ACOMON AG (CH) | 2014-09-09 | — | — | US | disclosed |
| US-20110251301-A1 | POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE | ACOMON AG (CH) | 2011-10-13 | — | — | US | disclosed |
| EP-2337805-A1 | POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE | ACOMON AG (CH) | 2011-06-29 | — | — | EP | disclosed |
| WO-2010043392-A1 | POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE | ACOMON AG (CH) | 2010-04-22 | — | — | WO | disclosed |
| EP-1157055-B1 | THERMOSETTING POLY URETHANE/UREA-FORMING COMPOSITIONS | CROMPTON CORP (US) | 2005-12-14 | — | — | EP | disclosed |
| US-6369156-B1 | CURABLE MIXTURE; AROMATIC POLYAMINE CONTAINING THIOETHER GROUP, PHOSPHATE ESTER, AND ALDEHYDE OR ALDEHYDE-FORMING COMPOUND; DISCOLORATION INHIBITION | VANTICO INC. | 2002-04-09 | — | — | US | disclosed |
| EP-1157055-A1 | THERMOSETTING POLY URETHANE/UREA-FORMING COMPOSITIONS | Vantico AG (CH) | 2001-11-28 | — | — | EP | disclosed |
| EP-1097952-A1 | Polurethane/Polyurea-forming compositions | Vantico AG (CH) | 2001-05-09 | — | — | EP | disclosed |
| WO-2000035983-A1 | THERMOSETTING POLY URETHANE/UREA-FORMING COMPOSITIONS | VANTICO AG (CH) | 2000-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10252988-B2 | Composition for producing transparent polythiourethane bodies | PHOSPHO1, PCTP, AGPAT5 | CYP3A4 2713/4885TSHR 2486/4885HPGD 2022/4885 |
| US-10294198-B2 | Method for producing xylylene diisocyanates in the gaseous phase | DCXR, DAD1, PAG1 | CYP3A4 715/4885TSHR 4447/4885HPGD 206/4885 |
| US-20170210702-A1 | METHOD FOR PRODUCING XYLYLENE DIISOCYANATES IN THE GASEOUS PHASE | DCXR, DAD1, PAG1 | CYP3A4 715/4885TSHR 4447/4885HPGD 206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.